Morgan Stanley Reiterates Overweight Rating on Eli Lilly (LLY)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq climbs over 1% as SpaceX, Super Micro improve AI sentiment
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Nvidia’s Huang highlights AI benefits in Berlin speech amid wider European tour
- AI bubble about to burst? Not yet, Yardeni says
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1269.53 -14.13 (1.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1283.66 | 52 Week High | $88.16 | |||
| Open | $1266.91 | 52 Week Low | $67.88 | |||
| Day High | $1279.28 | P/E | 293.87 | |||
| Day Low | $1261.08 | EPS | $4.32 | |||
| Volume | 823,721 | |||||
